Treatment of Asthma in Pregnancy

Clinical scenario

This protocol applies to pregnant patients with asthma — a combination that requires sustained attention to respiratory control throughout gestation.

Asthma exacerbations during pregnancy are associated with increased risks of pre-term delivery, low birth weight, and increased perinatal mortality. These outcomes make active, uninterrupted asthma management a clinical priority rather than a discretionary one.

Approach (partial)

Management is built around ICS-containing therapy, continued without interruption throughout pregnancy. Exacerbations are treated actively, on the same basis as in non-pregnant adults, to prevent fetal hypoxia. The complete sequenced protocol — including full decision criteria and management steps — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

All pregnant women with asthma should receive treatment that includes ICS, because asthma exacerbations are associated with increased risk of pre-term delivery, low birth weight and increased perinatal mortality, and these risks are reduced by ICS.
Usual asthma treatment should not be stopped.
Treat exacerbations as for non-pregnant adults, to avoid fetal hypoxia.

View source ↗